ABBOTT INDIA
Back to Income Statement
|
ABBOTT INDIA Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹6,409 Cr | ₹5,849 Cr | ₹5,349 Cr | ₹4,913 Cr | ₹4,310 Cr |
What is the latest Revenue of ABBOTT INDIA ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹6,409 Cr |
| Mar2024 | ₹5,849 Cr |
| Mar2023 | ₹5,349 Cr |
| Mar2022 | ₹4,913 Cr |
| Mar2021 | ₹4,310 Cr |
How is Revenue of ABBOTT INDIA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹6,409 Cr | 9.58 | |
| Mar2024 | ₹5,849 Cr | 9.35 | |
| Mar2023 | ₹5,349 Cr | 8.86 | |
| Mar2022 | ₹4,913 Cr | 14.00 | |
| Mar2021 | ₹4,310 Cr | - | |
Compare Revenue of peers of ABBOTT INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ABBOTT INDIA | ₹58,999.2 Cr | 0.2% | -1.8% | 0.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹391,488.0 Cr | -2.5% | -7% | -8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,415.0 Cr | -2.2% | -7.2% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,906.0 Cr | -4% | 2.8% | 27.1% | Stock Analytics | |
| CIPLA | ₹106,210.0 Cr | -5.5% | -12.4% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,089.0 Cr | 5.9% | -3.7% | -6.5% | Stock Analytics | |
ABBOTT INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ABBOTT INDIA | 0.2% |
-1.8% |
0.1% |
| SENSEX | -2.4% |
-4.7% |
6.4% |
You may also like the below Video Courses